A detailed history of Bruce & Co., Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Bruce & Co., Inc. holds 268,500 shares of PFE stock, worth $7.95 Million. This represents 3.67% of its overall portfolio holdings.

Number of Shares
268,500
Previous 268,500 -0.0%
Holding current value
$7.95 Million
Previous $7.73 Million 3.62%
% of portfolio
3.67%
Previous 3.95%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $6.56 Million - $8.52 Million
-251,000 Reduced 48.32%
268,500 $7.73 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $613,753 - $717,416
-19,126 Reduced 3.55%
519,500 $17.2 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $160,474 - $208,914
-4,074 Reduced 0.75%
538,626 $22 Million
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $45,750 - $56,690
-1,000 Reduced 0.18%
542,700 $28.1 Million
Q4 2021

Feb 16, 2022

SELL
$41.32 - $61.25 $41,320 - $61,250
-1,000 Reduced 0.18%
543,700 $32.1 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $860,831 - $1.11 Million
-21,932 Reduced 3.87%
544,700 $23.4 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $35,910 - $40,680
-1,000 Reduced 0.18%
566,632 $22.2 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $1.67 Million - $1.88 Million
49,800 Added 9.62%
567,632 $20.6 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $292,410 - $379,170
9,000 Added 1.77%
517,832 $18.6 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $1.72 Million - $1.93 Million
-46,500 Reduced 8.37%
508,832 $22 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $3.19 Million - $3.7 Million
100,000 Added 21.96%
555,332 $19.7 Million
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $14.1 Million - $15.5 Million
455,332
455,332 $16.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bruce & Co., Inc. Portfolio

Follow Bruce & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bruce & Co., Inc. with notifications on news.